FUNDED December 2022
Techboard's monthly roundup catalogues December 2022 startup raises, led by Synchron's $110m Series C, with health and biotech taking the largest share and 55 funding events captured totalling $546m.
Startup · $10.7m raised · Biotech and pharma
Every investor coverage indicates participated in a round BiomeBank raised.
| Investor | Rounds | Invested |
|---|---|---|
| Ellerston Capital | Unnamed stage | - |
| South Australian Venture Capital Fund | Unnamed stage | - |
| The Hospital Research Foundation | Unnamed stage | - |
Investors whose own portfolio pages list BiomeBank, even though we haven't found any coverage of the round yet.
| Investor | Listed on |
|---|---|
| Artesian VC | its portfolio page ↗ |
| Artesian VC | its portfolio page ↗ |
Companies BiomeBank acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Chris Hall | Chair | Forbes Australia |
| Dr Rob Bryant | VP Clinical Translation and Co-founder | SmartCompany, BiomeBank team page |
| Dr Sam Costello | Chief Executive Officer & Co-founder | SmartCompany, Forbes Australia, BiomeBank team page |
Stories naming BiomeBank. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Techboard's monthly roundup catalogues December 2022 startup raises, led by Synchron's $110m Series C, with health and biotech taking the largest share and 55 funding events captured totalling $546m.
Weekly roundup covering 14 startup raises totalling over $260 million, headlined by Synchron's $110 million round, plus Roller's shareholder liquidity payout, Partly's record New Zealand Series A, and several government grants.
Also GrainCorp Ventures·SmartCompany·Startup Daily·SmartCompany·@AuManufacturing·SmartCompany·Startup Daily·Startup Daily·Techboard·SmartCompany·SmartCompany·SmartCompany·SmartCompany·Startup Daily·SmartCompany·Startup Daily·@AuManufacturing·Startup News (WA)·Startup News (WA)
Biotech firm BiomeBank raised $10.65 million from Ellerston Capital, the South Australian Venture Capital Fund and The Hospital Research Foundation to expand manufacturing and advance its microbiome therapies.
Also SmartCompany·Techboard